Page Title goes here

Pharmanumbers Consulting

Services

We help drug delivery companies better understand the real-world opportunities for their biopharmaceutical products. We specialize in:

• qualitative product positioning using our ESCP and industry standard methodologies
• new product forecasting using our PharmaLadder methodology (dollar and unit sales, net present values, partnering profit distributions
• deal valuations and partnering terms development
• partnering analysis and positioning for success
• benchmarking product, market and competitive performance
• market research analysis in collaboration with our partners
• value of time calculations using Pharmanumbers methodology to estimate the value of gained and lost development time

Scope of Projects

We have helped numerous companies ranging from entrepreneur led start ups to publicly traded companies better understand and position their products and pipelines. We work effectively with R&D teams, commercial groups, management and boards. Our projects have included:

• Developing a full product forecast, opportunity analysis and NPV for a potential in-license product at a Phase II stage.
• Preparing a financial and strategic benchmarking analysis for four separate research stage product concepts.
• Providing a market and product analysis for use in partnering discussions.
• Development of partnering strategy and terms.
• Participating in partnering discussions to present product opportunities, forecasts and handle partner concerns.
• Working with division management and staff to review and revise strategy for the next five year cycle.
• Developing and presenting product forecasts and strategy to investment bankers in support of financing.

We have worked with Drug Delivery, Specialty Pharma, and Biopharma, companies. Give us a call to discuss how we can help you capture more value from your pipeline products.

Philosophy

We believe in being direct and pointing out both opportunities and threats. Ignoring the obvious, or not so obvious, is a recipe for disaster. Reality bites, and it's best not to be too surprised.

We believe that by knowing, even owning, the numbers, an individual, a product, and a company put themselves in a much better position to succeed. We see too many companies that fail to properly investigate a product opportunity at an early stage of development to find later that it either doesn't offer any real benefits, or the competitive environment is more than they can handle. Knowing the numbers is not only a key to success, it can help eliminate the waste that accompanies chasing illusionary opportunities.

We believe in creativity. Meaningful new products result from insight and imagination mixed with a good understanding of current and future trends. While past performance is no guarantee of future outcomes, is is said that history does not repeat but it often rhymes. Understanding where business is coming from helps us model where it is headed.

We do not believe in the concept of plausible deniability. Once you start to look closely at an opportunity you not only find opportunity, you uncover weaknesses and threats. If you never look under the rock you can plausibly deny the existence of bugs and worms. But if those bugs and worms can impact your product outcomes you owe it to your shareholders to know this. We like looking under rocks. Generally we find the bugs and worms are easily handled, and the more interesting things hiding under rocks can point to opportunities we might never have considered.

We like numbers and how they can help us develop better product strategies. If you listen closely, and understand the dialect, numbers speak to the future.